Abstract
IL-36 cytokines have recently emerged as mediators of inflammation in autoimmune conditions including psoriasis vulgaris (PsV) and generalized pustular psoriasis (GPP). This study used RNA-seq to profile the transcriptome of primary epidermal keratinocytes (KCs) treated with IL-1B, IL-36A, IL-36B, or IL-36G. We identified some early IL-1B-specific responses (8 h posttreatment), but nearly all late IL-1B responses were replicated by IL-36 cytokines (24 h posttreatment). Type I and II interferon genes exhibited time-dependent response patterns, with early induction (8 h) followed by no response or repression (24 h). Altogether, we identified 225 differentially expressed genes (DEGs) with shared responses to all 4 cytokines at both time points (8 and 24 h). These involved upregulation of ligands (IL1A, IL1B, and IL36G) and activating proteases (CTSS) but also upregulation of inhibitors such as IL1RN and IL36RN. Shared IL-1B/IL-36 DEGs overlapped significantly with genes altered in PsV and GPP skin lesions, as well as genes near GWAS loci linked to autoimmune and autoinflammatory diseases (e.g., PsV, psoriatic arthritis, inflammatory bowel disease, and primary biliary cholangitis). Inactivation of MyD88 adapter protein using CRISPR/Cas9 completely abolished expression responses of such DEGs to IL-1B and IL-36G stimulation. These results provide a global view of IL-1B and IL-36 expression responses in epidermal KCs with fine-scale characterization of time-dependent and cytokine-specific response patterns. Our findings support an important role for IL-1B and IL-36 in autoimmune or autoinflammatory conditions and show that MyD88 adaptor protein mediates shared IL-1B/IL-36 responses.
Highlights
The IL-36 cytokines (IL-36A, IL-36B, and IL-36G) are recent additions to the IL-1 family with potent pro-inflammatory effects on epithelial tissues in skin and other organs [1]
Whole transcriptome sequencing (RNA-seq) was used to profile expression of KCs treated with IL-1B, IL-36A, IL-36B, or IL-36G (8 or 24 h treatment; n = 2–3 samples per treatment and time point; n = 34 samples total)
We identified early IL-1B-specific responses involving genes contributing to epidermal development and mitosis, along with time-dependent IL-1B and IL-36 responses of type I and II interferon genes
Summary
The IL-36 cytokines (IL-36A, IL-36B, and IL-36G) are recent additions to the IL-1 family with potent pro-inflammatory effects on epithelial tissues in skin and other organs [1]. These cytokines are produced by diverse immune cells, including T cells, dendritic cells, plasma cells, and monocytes, in skin epidermal keratinocytes (KCs) appear to be the most prominent source [2]. These findings have intensified research focus on IL-36 ligands and their regulatory proteins, with the hope that anti-IL-36 therapies can provide treatment options for cutaneous and non-cutaneous diseases, similar to the success of other anticytokine biologics demonstrating efficacy in recent years [9]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have